Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.

PHASE4CompletedINTERVENTIONAL
Enrollment

1,538

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

September 26, 2021

Study Completion Date

September 26, 2021

Conditions
ComplicationInfectionProstate Cancer
Interventions
DRUG

Ciprofloxacin

see study arms.

DRUG

Trimethoprim/Sulfamethoxazole

see study arms.

DRUG

Fosfomycin

see study arms.

DRUG

Pivmecillinam/augmentin

see study arms.

Trial Locations (13)

Unknown

Jeroen Bosch Hospital, 's-Hertogenbosch

Rijnstate, Arnhem

Bravis, Bergen op Zoom

Amphia Hospital, Breda

Catharina Hospital, Eindhoven

Zuyderland Hospital, Heerlen

Canisius Wilhelmina Hospital, Nijmegen

Radboud University Medical Center, Nijmegen

Bravis, Roosendaal

Zuyderland Hospital, Sittard

Elisabeth Tweesteden Hospital, Tilburg

Bernhoven Hospital, Uden

Isala, Zwolle

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER

NCT03228108 - Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. | Biotech Hunter | Biotech Hunter